T Pitkäjärvi

512 total citations
29 papers, 427 citations indexed

About

T Pitkäjärvi is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, T Pitkäjärvi has authored 29 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in T Pitkäjärvi's work include Blood Pressure and Hypertension Studies (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Pharmacology and Obesity Treatment (3 papers). T Pitkäjärvi is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Pharmacology and Obesity Treatment (3 papers). T Pitkäjärvi collaborates with scholars based in Finland, United Kingdom and Sweden. T Pitkäjärvi's co-authors include Mauno Vanhala, Jorma Takala, Heikki Vapaatalo, Kaija Seppä, Pekka Sillanaukee, Hannu Jokela, Timo Koivula, Pauli Ylitalo, Pasi Salmela and Pekka Reinikainen and has published in prestigious journals such as The American Journal of Cardiology, Clinical Pharmacology & Therapeutics and Atherosclerosis.

In The Last Decade

T Pitkäjärvi

29 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Pitkäjärvi Finland 11 164 128 93 76 66 29 427
PR Jackson United Kingdom 11 117 0.7× 115 0.9× 47 0.5× 83 1.1× 14 0.2× 21 459
V. Malerczyk Germany 15 122 0.7× 42 0.3× 262 2.8× 51 0.7× 71 1.1× 46 575
Richard J. Fruncillo United States 12 53 0.3× 65 0.5× 166 1.8× 48 0.6× 50 0.8× 29 719
D Grafnetter Czechia 11 109 0.7× 64 0.5× 21 0.2× 84 1.1× 47 0.7× 55 426
A.D. Mackay United Kingdom 10 73 0.4× 47 0.4× 35 0.4× 36 0.5× 41 0.6× 25 378
G. Ferns United Kingdom 16 349 2.1× 186 1.5× 56 0.6× 252 3.3× 132 2.0× 40 975
Sarah Woolsey Canada 10 128 0.8× 89 0.7× 33 0.4× 75 1.0× 119 1.8× 15 501
P. Reissell Finland 12 65 0.4× 110 0.9× 37 0.4× 63 0.8× 38 0.6× 21 350
A. Quintanilla United States 11 40 0.2× 73 0.6× 50 0.5× 52 0.7× 66 1.0× 46 494
Sounira Mehri Tunisia 13 114 0.7× 180 1.4× 42 0.5× 42 0.6× 46 0.7× 50 419

Countries citing papers authored by T Pitkäjärvi

Since Specialization
Citations

This map shows the geographic impact of T Pitkäjärvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Pitkäjärvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Pitkäjärvi more than expected).

Fields of papers citing papers by T Pitkäjärvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Pitkäjärvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Pitkäjärvi. The network helps show where T Pitkäjärvi may publish in the future.

Co-authorship network of co-authors of T Pitkäjärvi

This figure shows the co-authorship network connecting the top 25 collaborators of T Pitkäjärvi. A scholar is included among the top collaborators of T Pitkäjärvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Pitkäjärvi. T Pitkäjärvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sillanaukee, Pekka, Timo Koivula, Hannu Jokela, T Pitkäjärvi, & Kaija Seppä. (2000). Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL3 cholesterol. Atherosclerosis. 152(2). 503–510. 35 indexed citations
2.
Vanhala, Mauno, Esko Kumpusalo, T Pitkäjärvi, Irma‐Leena Notkola, & Jorma Takala. (1997). Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women. Journal of Hypertension. 15(5). 475–481. 25 indexed citations
3.
Vanhala, Mauno, et al.. (1997). 'Metabolic Syndrome' in a Middle-Aged Finnish Population. European Journal of Cardiovascular Prevention & Rehabilitation. 4(4). 291–295. 44 indexed citations
4.
Nikkilä, Matti, T Pitkäjärvi, Timo Koivula, et al.. (1996). Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis. 119(2). 181–190. 52 indexed citations
5.
Pitkäjärvi, T, et al.. (1996). Norfloxacin and Salmonella Excretion in Acute Gastroenteritis – a 6-Month Follow-up Study. Scandinavian Journal of Infectious Diseases. 28(2). 177–180. 8 indexed citations
6.
Pitkäjärvi, T, et al.. (1991). Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children. Scandinavian Journal of Infectious Diseases. 23(4). 459–465. 12 indexed citations
7.
Nikkilä, Matti, et al.. (1991). Elevated high-density-lipoprotein cholesterol and normal triglycerides as markers of longevity. Journal of Molecular Medicine. 69(17). 780–785. 11 indexed citations
8.
Pitkäjärvi, T, et al.. (1990). Pivmecillinam treatment in acute cystitis. Three versus seven days study.. PubMed. 40(10). 1156–8. 19 indexed citations
9.
Cox, David A., et al.. (1987). Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension. The American Journal of Cardiology. 59(14). G61–G67. 59 indexed citations
10.
Karma, Anni, et al.. (1987). Predicting Diabetic Retinopathy. Acta Ophthalmologica. 65(S182). 136–139. 5 indexed citations
11.
Halttunen, P, T Pitkäjärvi, Laura Pöyhönen, et al.. (1986). A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.. British Journal of Clinical Pharmacology. 21(S1). 55S–62S. 66 indexed citations
12.
Karma, Alain, et al.. (1986). [Diabetic retinopathy and prediction of its severity].. PubMed. 102(21). 1575–85. 1 indexed citations
13.
Pitkäjärvi, T, et al.. (1985). Pivmecillinam in the treatment of acute cystitis. Current Therapeutic Research. 37(2). 184–190. 1 indexed citations
14.
Ylitalo, Pauli, H Oksala, & T Pitkäjärvi. (1985). Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.. PubMed. 35(10). 1596–9. 4 indexed citations
15.
Ylitalo, Pauli, et al.. (1985). Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. Clinical Pharmacology & Therapeutics. 38(4). 443–449. 21 indexed citations
16.
Oksa, Heikki, et al.. (1981). Self-poisoning patients in an intensive care unit.. PubMed. 13(2). 96–101. 5 indexed citations
17.
Pitkäjärvi, T, Pauli Ylitalo, T. Metsä‐Ketelä, & Heikki Vapaatalo. (1979). The Effects of a Beta1‐Blocking Agent, Atenolol, on Blood Pressure, Plasma Renin Activity and Prostaglandin F2α Excretion in Patients with Essential Hypertension. Acta Medica Scandinavica. 206(1-6). 107–113. 8 indexed citations
18.
Ylitalo, Pauli, T Pitkäjärvi, T. Metsä‐Ketelä, & Heikki Vapaatalo. (1978). The effect of inhibition of prostaglandin synthesis on plasnta renin activity and blood pressure in essential hypertension. Prostaglandins and Medicine. 1(6). 479–488. 20 indexed citations
19.
Pitkäjärvi, T, et al.. (1977). Antihypertensive drug combinations: prazosin, hydrochlorothiazide and clonidine.. PubMed. 9(5). 296–300. 2 indexed citations
20.
Pitkäjärvi, T, et al.. (1976). The use of clonidine and practolol in the treatment of hypertension.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(1). 48–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by PR Jackson Breakdown of academic impact, for papers by V. Malerczyk Breakdown of academic impact, for papers by Richard J. Fruncillo Breakdown of academic impact, for papers by D Grafnetter Breakdown of academic impact, for papers by A.D. Mackay Breakdown of academic impact, for papers by G. Ferns Breakdown of academic impact, for papers by Sarah Woolsey Breakdown of academic impact, for papers by P. Reissell Breakdown of academic impact, for papers by A. Quintanilla Breakdown of academic impact, for papers by Sounira Mehri
Rankless by CCL
2026